Pan-Cell Death Protein Signature as a Novel Diagnostic and Prognostic Biomarker for Intracerebral Hemorrhage
Tianhong Wang, Wenbiao Huang, Zhe Li, Zhiwei Cao, Kuairong Pu, Dongchuan Shao, Jun Wu, Jin Li, Nan Zhao
2026.2.24Journal of Proteome Research
Paper details
- Journal
- Journal of Proteome Research
- Published
- 2026.2.24
- Citations
- 0
- References
- 44
- Fields
- Medicine
tlooto Summary
This pan-cell death protein signature provides valuable insights into ICH pathology and offers a promising tool for early diagnosis, risk stratification, and therapeutic targeting.
Abstract
Intracerebral hemorrhage (ICH) remains a major cause of morbidity and mortality, with no rapid blood-based biomarkers available to assess secondary brain injury. This study aimed to identify a circulating pan-cell death protein signature for diagnosing and prognosing ICH. We prospectively enrolled 60 ICH patients and 60 age/sex-matched healthy controls, collecting plasma at defined time points after ICH onset. Using Olink proteomics, we identified 13 apoptosis-related proteins with significant dysregulation. Four key proteins─TLR4, ALOX15, FTL, and BMF─were validated through ELISA and RT-qPCR, showing good diagnostic performance (AUCs 0.799-0.835). A multiprotein logistic model demonstrated excellent diagnostic accuracy (AUC = 0.955). These biomarkers correlated with clinical severity and prognosis, including hematoma volume and a 90-day modified Rankin Scale (mRS). Additionally, animal models confirmed time-dependent upregulation of TLR4 in astrocytes. This pan-cell death protein signature provides valuable insights into ICH pathology and offers a promising tool for early diagnosis, risk stratification, and therapeutic targeting.
Citation format
WANG, Tianhong, et al. Pan-cell death protein signature as a novel diagnostic and prognostic biomarker for intracerebral hemorrhage. Journal of Proteome Research, 2026, 25(3): 1544–1555.